Koers DermTech, Inc. Nasdaq
Aandelen
VGG2379F1247
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 16,83 mln. 15,62 mln. | Omzet 2025 * | 20,63 mln. 19,16 mln. | Marktkapitalisatie | 21,63 mln. 20,08 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -77 mln. -71,5 mln. | Nettowinst (verlies) 2025 * | -73 mln. -67,78 mln. | EV/omzet 2024 * | 1,29 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,05 x |
K/w-verhouding 2024 * |
-0,28
x | K/w-verhouding 2025 * |
-0,3
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 47,95% |
Recentste transcriptie over DermTech, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bret Christensen
CEO | Chief Executive Officer | 53 | 08-05-23 |
Kevin Sun
DFI | Director of Finance/CFO | 46 | 01-08-19 |
Steven Stone
CTO | Chief Tech/Sci/R&D Officer | - | 28-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kirk Malloy
BRD | Director/Board Member | 57 | 18-07-22 |
Mark Capone
BRD | Director/Board Member | 61 | 18-07-22 |
Cynthia Collins
BRD | Director/Board Member | 65 | 03-09-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,29% | 12,64 mld. | |
-0,47% | 8,46 mld. | |
+22,61% | 5,27 mld. | |
-2,03% | 4,49 mld. | |
-53,56% | 3,11 mld. | |
+19,30% | 2,87 mld. | |
+33,07% | 2,31 mld. | |
-8,42% | 2,23 mld. | |
-3,55% | 1,89 mld. |